Gabapentin is an anticonvulsant used off-label to help prevent migraine attacks. Learn about why it’s used and how it works. Objective: To compare efficacy and safety of gabapentin (GPT) versus placebo for prophylaxis of chronic daily headache (CDH) (headache at least 15 days/month of greater than 4 hours duration over preceding 6 months). Methods: This is a multicenter Gabapentin is used "off-label" for migraine prevention and treatment, including migraines with or without aura, vestibular migraines. It reduces the frequency of headaches, pain intensity, and the use of symptomatic medications 1 , 2 . Headache subtype Diagnostic criteria Nonpharmacologic treatment options Gabapentin (Neurontin) is minimally effective at high doses, and adverse effects are common. So I have to say, I have definitely had my share of headaches since I started Gabapentin about a year ago. It's taken that long to find a happy spot for me. I'm an engineer and in grad school at night, I can't afford to have my seizures or migraines out of control, Gabapentin has been good for me. I hope this helps !!! Many of the drugs used for migraine prophylaxis are associated with significant adverse side effects. Given the efficacy of gabapentin in migraine prophylaxis and its good tolerability profile, it should be considered an important addition in the management of patients who are candidates for migraine prophylaxis. Migraine is a primary headache disorder characterized by recurrent attacks. Approximately 44.5 million U.S. adults (18% to 26% of women and 6% to 9% of men) have experienced a migraine, according Gabapentin is an effective prophylactic agent for patients with migraine. In addition, gabapentin appears generally well tolerated with mild to moderate somnolence and dizziness. Off-label, gabapentin has been used in the treatment of migraine and other types of headache, including cluster and tension headaches. It shows potential as an option for those living with migraine and other headache disorders. To describe and assess the evidence from controlled trials on the efficacy and tolerability of gabapentin/gabapentin enacarbil or pregabalin for preventing migraine attacks in adult patients with episodic migraine. A 2016 study found that gabapentin showed some benefits for migraine headaches. However, it concluded that there wasn't enough evidence to recommend it as a primary therapy. Another study review in 2023 found that gabapentin was no more effective than a placebo in reducing monthly migraine days. Does gabapentin (Neurontin) help prevent episodic migraine? Evidence-Based Answer Gabapentin does not decrease the frequency of migraine headaches and is not recommended for Gabapentin is FDA-approved as Neurontin to treat partial seizures in adults and children with epilepsy. Partial seizures are convulsions that originate from a single location in the brain. Neurontin is also approved to treat a type of nerve pain called postherpetic neuralgia, or PHN. Reviews and ratings for Gabapentin when used in the treatment of migraine. 121 reviews submitted with a 7.9 average score. Objective: Gabapentin (GBP), originally an antiepileptic drug, is more commonly used in the treatment of pain, including headache disorders. Off-label GBP is used in headache disorders with some success, some failure, and much debate. However, researchers weren't able to tease out the sequence of when people took the drugs. And with anti-nausea drugs, it's not clear if people were rating their helpfulness on nausea rather than headache, Dr. Loder points out. But it's a good reminder that for many people who have migraines, nausea and vomiting are a big problem. If you have migraines regularly for a long time, treatment can help. Sometimes you can use the drug Lyrica to prevent them. Your doctor may suggest this daily drug if you need to treat another Despite the conflicting evidence surrounding select studies, a significant amount of evidence shows that GBP has benefit for a majority of primary headache syndromes, including chronic daily headaches. GBP has some efficacy in migraine headache, but not sufficient evidence to suggest primary therapy. Migraines impose significant health and financial burdens. Approximately 38% of patients with episodic migraines would benefit from preventive therapy, but less than 13% take prophylactic medications. One trial each of gabapentin 900 mg (53 patients), and gabapentin titrated to 1200 mg (63 patients) and 1800 mg (122 patients) failed to show a statistically significant reduction in headache frequency in the active treatment group as compared to the placebo group, whereas one trial of gabapentin titrated to 1800 to 2400 mg (113 patients
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | |
![]() | |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |